NCT06615115Recruiting
The Effect of Different Types of Focus Instructions in Parkinson's Rehabilitation
Effects of an External and Combined Focus of Attention-Instructed Exercise Program on Postural Stability and Dual-Task Walking in Parkinson's Disease: A Randomized, Assessor-Blinded, Controlled Trial
Source: ClinicalTrials.gov · Last updated 11 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Parkinson's disease is the most common progressive neurodegenerative movement disorder. Common movement impairments in Parkinson's include balance and walking difficulties. These impairments lead to falls, increased levels of functional dependency, and a decrease in quality of life. Exercise in Parkinson's patients improves their functional symptoms in daily life, enhancing both motor and non-motor skills, and consequently increases their quality of life. Recently, various additional methods have been developed to increase the effectiveness of exercise in Parkinson's rehabilitation and to contribute to motor skills. Focus of attention instructions are fundamental concepts in motor function learning. External focus of attention has been shown to facilitate motor function development, reduce postural instability, and improve dual-task walking by being easier to remember. In Parkinson's patients who experience freezing phenomena, internal focus of attention instructions enhance walking stability and movement control, thereby reducing the risk of falls. However, there are no studies on the combined focus of attention instructions in Parkinson's patients. This study is designed as a randomized controlled, single-blind, prospective trial to examine the effects of a combination of internal and external focus of attention instructions on walking, balance parameters, quality of life, and patient satisfaction levels, taking into account the presence of freezing phenomena in Parkinson's patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 24 Sept 2024
- Start date
- 30 Jan 2025
- Primary completion date
- 30 May 2025
- Lead sponsor
- Bahçeşehir University
- Diseases
- Parkinson disease
- NCT number
- NCT06615115
What you commit to
- Study type: Interventional
- Planned participants: 48
- From 30 Jan 2025 to the primary completion date, 30 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having malignancy and metabolic diseases
- Other neurological disease history
- Presence of visual or hearing disorders
Other
- Having had Cerebrovascular Accident before
- Presence of cognitive problems
- Presence of deep brain pacemaker
- Presence of freezing phenomenon (persons with Freezing of Gait Questionnaire FOG-Q above zero)
- Presence of dyskinesia
Who the study is looking for
- Hoehn and Yahr Stage II or III
- Individuals between the ages of 50 and 70 who can walk independently but have balance disorders
- Having a score between 21-56 on the Berg Balance Scale
- Having a score between 24-30 on the Mini Mental State Test
- Having agreed to participate in the study (Not having a freezing phenomenon)
- Being in the Medication-on period
Age in the registry: 50 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atafiz Tıp Merkezi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.